An increase in catecholamines and metabolites in the amniotic fluid compartment from middle to late gestation.
By means of a modified radioenzymatic assay, simultaneous determinations of the parent catecholamines, epinephrine (E), norepinephrine (NE), and dopamine (DA), and their deaminated metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and 3,4-dihydroxyphenylglycol (DOPEG), were made in amniotic fluid obtained during the second (N = 44) and third (N = 20) trimesters of normal pregnancies. Significant positive correlations were noted between gestational age and concentrations of E, NE, DA, DOPAC, and DOPEG in amniotic fluid. These findings provide evidence of progressive fetal adrenergic maturation through pregnancy. In addition, our data suggest a parallel maturational event in the central nervous and peripheral catecholamine systems of the fetus, since DOPAC and DOPEG are more representative of catecholamine neuronal activity in the brain.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000032:analysis; D000653:Amniotic Fluid / Q000032:analysis*; D002395:Catecholamines / Q000032:analysis*; D004298:Dopamine / Q000032:analysis; D004837:Epinephrine / Q000032:analysis; D005260:Female; D005865:Gestational Age; D006801:Humans; D008734:Methoxyhydroxyphenylglycol / Q000031:analogs & derivatives / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third
D002395:Catecholamines; D015102:3,4-Dihydroxyphenylacetic Acid; D008734:Methoxyhydroxyphenylglycol; C010117:3,4-dihydroxyphenylglycol; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine